医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Takeda Appoints New Chief Financial Officer, James Kehoe

2016年05月12日 PM03:00
このエントリーをはてなブックマークに追加


 

OSAKA, Japan

Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO:4502) today announced the appointment of James Kehoe as Takeda’s new Chief Financial Officer and Corporate Officer, effective on June 15, 2016. Mr. Kehoe will be based in Tokyo and reports directly to Christophe Weber, President & CEO of Takeda.

“James Kehoe’s passion for transforming large organizations to achieve higher performance will hold him in good stead as he leads the Global Finance team to further elevate the company’s business performance and help Takeda deliver its growth ambitions,” said Christophe Weber, President & CEO of Takeda. “We also believe that James’s values are very much aligned with Takeda’s values and that his personal style will work well with the Takeda Executive Team and the Finance Leadership Team.”

Mr. Kehoe is an accomplished finance executive from the Consumer Goods sector. He is a strong business leader, with a track record of improving operational business performance that includes process optimization. He joins Takeda from Kraft Foods Group in the U.S., where he most recently held the role of CFO. Prior to that, he has held a number of finance-related positions spanning the course of more than 20 years, with assignments based in Germany, Switzerland and Italy.

An Irish national, Mr. Kehoe holds a Bachelor of Commerce degree from the University College, Galway, Ireland, and an MSc in Finance from the University College Dublin, Ireland.

[ Reference: Career History of James Kehoe ]
2015-2015    

KRAFT FOODS GROUP (Food)

  USA
Chief Financial Officer & Executive Vice President
2015-2015

GILDAN ACTIVEWEAR (Clothes)

Canada
Chief Financial Officer & Executive Vice President
2013-2014

MONDELEZ (Food)

USA
Senior Vice President, Operating Excellence
1988-2013

KRAFT FOODS (Food)

USA etc.
Senior Vice President, Corporate Finance etc.
1986-1988

BERGER PAINTS (Paint material)

Ireland, Republic of (Eire)
Cost Accountant
1984-1986

CANADA DRY CORPORATION (Food)

Ireland, Republic of (Eire)
Assistant Management Accountant
 

About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited is a global, R&D-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its research efforts on oncology, gastroenterology and central nervous system therapeutic areas. It also has specific development programs in specialty cardiovascular diseases as well as late-stage candidates for vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, as well as its presence in emerging markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries. For more information, visit http://betterhealth.takeda.com/.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160511006679/en/

CONTACT

Takeda Pharmaceutical Company Limited
Investor Relations
Noriko
Higuchi, +81-(0)3-3278-2306
noriko.higuchi@takeda.com
or
Media
Relations

Tsuyoshi Tada, +81-(0)3-3278-2417
tsuyoshi.tada@takeda.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 三井化学开发全球首款灵活的高强度柔性无纺布AIRYFA™
  • APR应用制药研究公司参加第9届ChinaBio®合作论坛:依托瑞士创新产品和科学技术深耕中国市场
  • Dompé用于治疗中度或重度神经营养性角膜炎成人患者的Oxervate®(Cenegermin滴眼液)获得欧盟CHMP肯定意见
  • SCIEX Sponsored Award Recognizes Notable Contributions to Electrodriven Separations
  • LMDのV-Sensorがインドでバイタルサインを測定